VERNON W ANTHONY

SEC Form 4 insider trading activity

VERNON W ANTHONY has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including NVCR, MKC, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jun 5, 2026.

On the most recent filing, VERNON W ANTHONY is listed as Director at NovoCure Ltd. Inside the rolling window, VERNON W ANTHONY reported no open-market purchases and 1 open-market sale totaling $46K in NVCR.

Companies traded

Other insiders at NVCR

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$46K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
NVCR
VERNON W ANTHONY
Sale$46KJun 3SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has VERNON W ANTHONY made?

VERNON W ANTHONY has filed 4 SEC Form 4 filings (4 transaction rows) across 2 companies, including NVCR, MKC since 2026.

Which companies does VERNON W ANTHONY trade?

VERNON W ANTHONY has filed SEC Form 4 disclosures for 2 companies, including NVCR, MKC.

When was VERNON W ANTHONY's most recent SEC Form 4 filing?

VERNON W ANTHONY's most recent SEC Form 4 filing on Tracefour is dated Jun 5, 2026.

What is VERNON W ANTHONY's total buy and sell value in the current window?

Inside the rolling retention window, VERNON W ANTHONY bought $0 and sold $46K based on SEC Form 4 filings.

What was VERNON W ANTHONY's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 2,945 NVCR shares on 2026-06-02, worth $46K, per SEC Form 4 filings.